![Ira Wallis](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Ira Wallis has been Vice President of Regulatory Affairs for Tercica, Inc. since March 2003.
He was Senior Director and Head of Regulatory Affairs for Dynavax Technologies Corporation from May 2001 to January 2003 and a Director and Head of Regulatory Affairs for Cerus Corporation from July 1996 to April 2001.
Dr. Wallis was an Associate Director and Manager of Regulatory Affairs for Genentech, Inc. from 1990 to 1996 and Manager of Regulatory Affairs for Sandoz Pharmaceutical Corporation from 1987 to 1989.
He received a BA degree in Zoology from American International College and a PhD in Neurophysiology from the State University of New York.
Anciens postes connus de Ira Wallis
| Sociétés | Poste | Fin |
|---|---|---|
Tercica, Inc.
 Tercica, Inc. Pharmaceuticals: MajorHealth Technology Develops new therapeutics for endocrine system disorders | Conseiller Juridique Général | 03/02/2014 |
| DYNAVAX TECHNOLOGIES CORPORATION | Conseiller Juridique Général | 01/01/2003 |
| CERUS CORPORATION | Directeur/Membre du Conseil | 01/04/2001 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Conseiller Juridique Général | 01/01/1996 |
Sandoz Pharmaceuticals Corp. | Conseiller Juridique Général | 01/01/1989 |
Formation de Ira Wallis
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
88
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Cerus Corp.
 Cerus Corp. Medical SpecialtiesHealth Technology Develops and commercializes the INTERCEPT Blood System for platelets and plasma | Health Technology |
Dynavax Technologies Corp.
 Dynavax Technologies Corp. BiotechnologyHealth Technology Develops and commercializes novel products to prevent and treat infectious diseases | Health Technology |
Tercica, Inc.
Tercica, Inc. Pharmaceuticals: MajorHealth Technology Develops new therapeutics for endocrine system disorders | Health Technology |
American International College
 American International College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
State University of New York at Buffalo
 State University of New York at Buffalo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sandoz Pharmaceuticals Corp. |
